|

Mitomycin Clinical Trials

7 actively recruiting trials across 5 locations

No change since May 2026

Also known as: Ametycine, Jelmyto, MITO, Mito-C, Mito-Medac +13 more

Pipeline

Phase 1: 1Phase 2: 4Phase 3: 1Phase 1/2: 1

Top Sponsors

  • City of Hope Medical Center2
  • University of Chicago1
  • Roland Seiler-Blarer1
  • National Cancer Institute (NCI)1
  • NRG Oncology1

Indications

  • Cancer7
  • Stage I Bladder Cancer AJCC v82
  • Peritoneal Carcinomatosis2
  • Stage IVC Appendix Carcinoma AJCC v81
  • Stage IVB Appendix Carcinoma AJCC v81

Duarte, California2 trials

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

City of Hope Medical Center

Phase 1
Phase II Trial of Lung Chemoemobolization

City of Hope Medical Center

Phase 2

Other1 trial

Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived Organoids
Phase 2

Fayetteville, Arkansas1 trial

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Highlands Oncology Group - Fayetteville

Phase 2

Fort Smith, Arkansas1 trial

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Mercy Hospital Fort Smith

Phase 3

Jacksonville, Florida1 trial

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

Mayo Clinic in Florida

Phase 1/2

Chicago, Illinois1 trial

Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

University of Chicago

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.